China NMPA Product Recall - Fiberoptic endotracheal intubation endoscope

The National Medical Products Administration (NMPA) in China announced a Class II voluntary recall initiated by Olympus Medical Systems Co., Ltd., which was reported by its local entity, Olympus Trading (Shanghai) Co., Ltd., on November 1, 2023. This recall specifically targets certain fiberoptic endoscopic tubes, identified under National Standard No. 20142065689. The core issue driving this action is the discovery of an incorrect inspiratory volume specification printed on the product's inspection card. Such inaccuracies, even if seemingly minor, can have critical implications for the proper and safe use of medical devices, potentially affecting patient diagnostic or therapeutic procedures. The Class II designation signifies that the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is remote. As a result, Olympus Medical Systems Co., Ltd. is undertaking this voluntary corrective action to ensure the accuracy of product labeling and maintain device integrity in accordance with NMPA's stringent regulatory framework for medical products. Comprehensive details regarding the affected models, specifications, and batch numbers are provided in the "Medical Device Recall Event Report Form" submitted to the NMPA. This proactive measure underscores the company's commitment to compliance and patient safety.